Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens

13 Aug 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune responses and vaccinations
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34414383
DOI: 10.1016/j.medj.2021.08.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigensPMID 34414383Read ↗

Protective Heterologous T Cell Immunity in COVID-19 Induced by MMR and Tdap Vaccine AntigensSemantic proximity Read ↗

Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigensSemantic proximity Read ↗

Heterologous vaccine regimens against COVID-19Semantic proximity Read ↗

Vaccine efficacy against COVID-19: A foresight on the host-associated factorsSemantic proximity Read ↗

A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoVSemantic proximity Read ↗

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccineSemantic proximity Read ↗

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell ImmunitySemantic proximity Read ↗

First COVID-19 DNA vaccine approved, others in hot pursuitSemantic proximity Read ↗

A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccineSemantic proximity Read ↗

DNA vaccines join the fight against COVID-19Semantic proximity Read ↗

Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responsesSemantic proximity Read ↗

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.